대한화상학회지 (Journal of the Korean Burn Society)
- 제22권2호
- /
- Pages.45-48
- /
- 2019
- /
- 1229-0955(pISSN)
3도 화상에 대한 동종 상피세포 치료제의 효과 보고
Feasibility of Cultured Allogenic Keratinocyte Treatment for Third Degree Burns
- 최장연 (가톨릭대학교 의과대학 의정부성모병원 성형외과) ;
- 조진태 (가톨릭대학교 의과대학 의정부성모병원 성형외과) ;
- 최종윤 (가톨릭대학교 의과대학 의정부성모병원 성형외과) ;
- 서보미 (가톨릭대학교 의과대학 의정부성모병원 성형외과) ;
- 정성노 (가톨릭대학교 의과대학 의정부성모병원 성형외과)
- Choi, Jangyoun (Department of Plastic and Reconstructive Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
- Cho, Jin Tae (Department of Plastic and Reconstructive Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
- Choi, Jong Yun (Department of Plastic and Reconstructive Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
- Seo, Bommie Florence (Department of Plastic and Reconstructive Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
- Jung, Sung-No (Department of Plastic and Reconstructive Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
- 투고 : 2019.10.17
- 심사 : 2019.11.15
- 발행 : 2019.12.31
초록
Allogenic keratinocyte application is widely used for treatment of second degree burns. However, there is no significant body of report on application of allogenic keratinocyte to third degree burns. A geriatric patient visited our burn center showing second to third-degree burn on dorsum of her left hand. Considering the surface area and wound depth, surgery was indicated but her medical condition and age made the surgery high risk for a long operation. Therefore, chemical escharolysis, serial bedside debridement, and cultured allogenic keratinocyte (Kaloderm®, Tegoscience, Seoul, Korea) application was done. The wound was completely epithelialized after four rounds of Kaloderm® application. For third-degree burns where definitive surgical reconstruction is precluded due to medical comorbidity of the patient, we investigated the possibility of allogenic keratinocyte treatment which may allow to avoid high-risk anesthesia and surgery.